Abstract:Purpose: To provide an updated review of multimodal pain management in arthroscopic surgery by evaluating pain and opioid consumption after shoulder, knee, and hip arthroscopy. Methods: A comprehensive literature search was performed to identify randomized controlled trials (RCTs) investigating multimodal pain management after shoulder, knee, and hip arthroscopy. Articles were identified from January 2011 through December 2020 using various databases. As the primary outcome variables of this study, differences… Show more
“…Third, this study only included the use of adjunctive oral medications and did not include the use of regional anesthesia (aside from peri‐incisional local anesthetic infiltration). However, prior systematic reviews have only reported a significant improvement in pain and reduction in opioid use in a single included clinical trial evaluating the efficacy of femoral nerve blocks in hip arthroscopy; however, this does carry an associated risk of falls [21, 31]. Further study is required of adjunctive regional anesthesia techniques to determine if alternative blocks may provide improved pain control without added perioperative risk.…”
Section: Discussionmentioning
confidence: 99%
“…While reducing opioid prescriptions is essential, effective pain management is important to improve patient satisfaction and clinical outcomes, particularly when considering ambulatory surgical procedures where successful discharge and avoidable readmissions are tied to the adequacy of postoperative analgesia [1]. The use of multimodal analgesia to improve pain control is gaining significant attention, particularly in sports medicine, with recent publications demonstrating efficacy in shoulder and knee surgery [10, 16, 21]. However, its use and efficacy in hip arthroscopy are incompletely understood.…”
PurposeTo determine whether different regimens of multimodal analgesia will reduce postoperative pain scores, opioid consumption, costs and hospital length‐of‐stay following hip arthroscopy.
MethodsFrom 2018 to 2021, 132 patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) were included in this prospective, single‐center randomized controlled trial. Patients were randomized into four treatment groups:
Group 1—Control: opioid medication (oxycodone‐acetaminophen 5 mg/325 mg, 1–2 tabs q6H as needed), Heterotopic ossification prophylaxis—Naprosyn 500 mg twice daily × 3 weeks);
Group 2—Control + postoperative sleeping aid (Zopiclone 7.5 mg nightly × 7 days);
Group 3—Control + preoperative and postoperative Gabapentin (600 mg orally, 1 h preoperatively; 600 mg postoperatively, 8 h following pre‐op dose);
Group 4—Control + pre‐medicate with Celecoxib (400 mg orally, 1 h preoperatively)
The primary outcome was pain measured with a visual analog scale, monitored daily for the first week and every other day for 6 weeks. Secondary outcomes included opioid consumption, healthcare resource use, and hospital length of stay.
ResultsPatient characteristics were similar between groups. There were no statistically significant differences in pain scores between groups at any timepoint after adjusting for intra‐operative traction time, intra‐operative opioid administration and preoperative pain scores (p > 0.05). There were also no significant differences in the number of days that opioids were taken (n.s.) and the average daily morphine milligram equivalents consumed (n.s.). Similarly, there were no statistically significant differences in length of stay in the experimental groups, compared with the control group (n.s.). Finally, there were no differences in cost between groups (n.s.).
ConclusionThe routine use of Zopiclone, Celecoxib and Gabapentin did not improve postoperative pain control or reduce length‐of‐stay following hip arthroscopy. Therefore, these medications are not recommended for routine postoperative pain control following hip arthroscopy.
Level of evidencel.
“…Third, this study only included the use of adjunctive oral medications and did not include the use of regional anesthesia (aside from peri‐incisional local anesthetic infiltration). However, prior systematic reviews have only reported a significant improvement in pain and reduction in opioid use in a single included clinical trial evaluating the efficacy of femoral nerve blocks in hip arthroscopy; however, this does carry an associated risk of falls [21, 31]. Further study is required of adjunctive regional anesthesia techniques to determine if alternative blocks may provide improved pain control without added perioperative risk.…”
Section: Discussionmentioning
confidence: 99%
“…While reducing opioid prescriptions is essential, effective pain management is important to improve patient satisfaction and clinical outcomes, particularly when considering ambulatory surgical procedures where successful discharge and avoidable readmissions are tied to the adequacy of postoperative analgesia [1]. The use of multimodal analgesia to improve pain control is gaining significant attention, particularly in sports medicine, with recent publications demonstrating efficacy in shoulder and knee surgery [10, 16, 21]. However, its use and efficacy in hip arthroscopy are incompletely understood.…”
PurposeTo determine whether different regimens of multimodal analgesia will reduce postoperative pain scores, opioid consumption, costs and hospital length‐of‐stay following hip arthroscopy.
MethodsFrom 2018 to 2021, 132 patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) were included in this prospective, single‐center randomized controlled trial. Patients were randomized into four treatment groups:
Group 1—Control: opioid medication (oxycodone‐acetaminophen 5 mg/325 mg, 1–2 tabs q6H as needed), Heterotopic ossification prophylaxis—Naprosyn 500 mg twice daily × 3 weeks);
Group 2—Control + postoperative sleeping aid (Zopiclone 7.5 mg nightly × 7 days);
Group 3—Control + preoperative and postoperative Gabapentin (600 mg orally, 1 h preoperatively; 600 mg postoperatively, 8 h following pre‐op dose);
Group 4—Control + pre‐medicate with Celecoxib (400 mg orally, 1 h preoperatively)
The primary outcome was pain measured with a visual analog scale, monitored daily for the first week and every other day for 6 weeks. Secondary outcomes included opioid consumption, healthcare resource use, and hospital length of stay.
ResultsPatient characteristics were similar between groups. There were no statistically significant differences in pain scores between groups at any timepoint after adjusting for intra‐operative traction time, intra‐operative opioid administration and preoperative pain scores (p > 0.05). There were also no significant differences in the number of days that opioids were taken (n.s.) and the average daily morphine milligram equivalents consumed (n.s.). Similarly, there were no statistically significant differences in length of stay in the experimental groups, compared with the control group (n.s.). Finally, there were no differences in cost between groups (n.s.).
ConclusionThe routine use of Zopiclone, Celecoxib and Gabapentin did not improve postoperative pain control or reduce length‐of‐stay following hip arthroscopy. Therefore, these medications are not recommended for routine postoperative pain control following hip arthroscopy.
Level of evidencel.
“…Patients returning to pharmacies for prescription renewal or acquisition of step-down medication may be targets for these interventions. Importantly, multimodal pain management strategies are proving effective in reducing postoperative opioid consumption in the orthopedic setting [16]. When combined with a multimodal strategy, point-of-service disposal interventions may further mitigate the risk of diversion of unused opioids.…”
IntroductionDiversion of unused prescription opioids is a common source of opioid sensitization in the community. Educating patients about safe opioid use has been shown to be effective in decreasing opioid use. However, decreasing diversion will also require educating patients on proper opioid disposal. A survey was administered to better understand patients' habits with opioid disposal for opioids prescribed after orthopedic surgery.
MethodsA cross-sectional survey study of 469 patients who had undergone orthopedic surgery was conducted to learn their preferences and habits regarding the disposal of unused prescription opioids received after orthopedic surgery.
ResultsThe survey respondents consisted of 48.8% female and 51.2% male patients. Ninety-four point two percent (94.2%) of those receiving opioid prescriptions reported having leftover unused opioids. In terms of voluntary disposal, 68.8% claimed to dispose of their prescription opioids while 31.2% did not. Gender, but not age, had a significant effect on plans for opioid disposal and how seriously respondents viewed issues of opioid misuse. When asked their preferred location for prescription opioid disposal, the most common preference was a local pharmacy.
DiscussionThis survey identified that most patients do not store their prescription opioids in a locked location, claim to dispose of their unused prescription opioids, and would prefer to dispose of them at a pharmacy if possible. This information points to the need for close prescriber-to-pharmacy collaboration to promote the safe disposal of prescription opioids and mitigate drug diversion.
“…In a subset of patients who had undergone TKA, nonpharmacological interventions were associated with moderate improvement in pain (Komann et al, 2019). Despite limited outcome data, the promotion of postoperative care that includes both passive and active interventions have demonstrated value (Cheah et al, 2022; Fan & Chen, 2020; Komann et al, 2019; Paul et al, 2021; Tedesco et al, 2017).…”
Section: Recommendations For Each Phase Of Carementioning
Orthopaedic surgery often results in pain, with less than half of patients reporting adequate relief. Unrelieved acute pain occurring after surgery increases the risk of negative sequelae, including delayed healing, increased morbidity, pulmonary complications, limited rehabilitation participation, anxiety, depression, increased length of stay, prolonged duration of opioid use, and the development of chronic pain. Interventions that are individualized, evidence-informed, and applied within an ethical framework improve healthcare delivery for patients, clinicians, and healthcare organizations. Recommendations for using the principles of effective pain management from preoperative assessment through discharge are detailed, including recommendations for addressing barriers and challenges in applying these principles into clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.